Can Postpartum Depression Be Prevented With Care

Sponsor
Ataturk University (Other)
Overall Status
Completed
CT.gov ID
NCT05295069
Collaborator
(none)
112
1
2
20.3
5.5

Study Details

Study Description

Brief Summary

This study was designed to eliminate postpartum insomnia and fatigue and reduce the risk of postpartum depression through the maintenance of structural, personal, and social integrity with holistic care under the guidance of Levine's conservation model for primiparous puerperal women who experience fatigue and are at risk of developing depression. : A single-blind pretest-posttest randomized controlled study. Women were called to the hospital on the 7th postpartum day and randomly assigned by a computer program to either the intervention group (n=56) or the control group (n=56). Participants did not know which group they were in.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: A nursing care program was applied for the intervention group under the guidance of Levine's conservation model.
N/A

Detailed Description

A nursing care program was prepared for the intervention group under the guidance of Levine's conservation model. This program was applied with 7 home visits between the 8th and 80th postpartum days. Face-to-face training and training booklets were provided in home visits. As of the fourth home visit, Pilates exercises were performed. The women in the control group received routine care. Pretest and posttest data were collected with a personal data sheet, visual analogue scale for fatigue, Postpartum Physical Symptom Severity Scale, Postpartum Sleep Quality Scale, Edinburgh Postpartum Depression Scale, and Postpartum Support Scale.

Sleep quality improved for the primiparous puerperal women of the intervention group. They had reduced postpartum fatigue and increased energy; maintained their structural, personal, and social integrity; and had decreased risk of developing postpartum depression with the holistic care provided (all p<0.001). A negative correlation was detected between the support subscale posttest total score from the Postpartum Support Scale and the posttest scores of the Edinburgh Postpartum Depression Scale for the women of the intervention group (r=-0.303; p<0.05)

Study Design

Study Type:
Interventional
Actual Enrollment :
112 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Masking Description:
All participants did not know which group they were in.
Primary Purpose:
Prevention
Official Title:
Can Postpartum Depression Be Prevented With Care Provided To Primiparas Using Levine's Conservation Model: Single-Blind Randomized Controlled Experimental Study
Actual Study Start Date :
Jul 1, 2019
Actual Primary Completion Date :
Apr 1, 2020
Actual Study Completion Date :
Mar 9, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: The intervention group

To reduce postpartum depression among the primiparous puerperal women in the intervention group, and a nursing care program was implemented under the guidance of Levine's model. This program was applied with 7 home visits between the 8th and 80th postpartum days. Face-to-face training and training booklets were provided in home visits. As of the fourth home visit, Pilates exercises were performed.

Behavioral: A nursing care program was applied for the intervention group under the guidance of Levine's conservation model.
Face-to-face training and training booklets were provided in home visits. As of the fourth home visit, Pilates exercises were performed.

No Intervention: The control group

In the control group women received routine postpartum care. No interventions were conducted other than routine postpartum care.

Outcome Measures

Primary Outcome Measures

  1. Visual Analogue Scale to Evaluate Fatigue Severity Scores [1- 7th day after giving birth, Time Frame: 2- postpartum 12th week]

    The highest score that can be obtained for the fatigue subdimension is 130 and the lowest score is 0. The highest score that can be obtained from the energy subdimension is 50 and the lowest score is 0. Higher scores on items measuring fatigue and lower scores on items measuring energy indicate that the severity of fatigue is high.

  2. Edinburgh Postpartum Depression Scale Scores [1- 7th day after giving birth, Time Frame: 2- postpartum 12th week]

    The highest score that can be obtained from the scale is 30. A score of 12 or more indicates that the individual is at risk of depression.

Secondary Outcome Measures

  1. The Postpartum Support Scale Scores [1- postpartum 8th day Time Frame: 2- Postpartum 12th week]

    The lowest score that can be obtained from the scale is 0 and the highest score is 238. The higher the total score, the greater the need for support and the greater the support that needs to be received.

  2. the Postpartum Sleep Quality Scale Scores [1- postpartum 8th day Time Frame: 2- Postpartum 12th week]

    The lowest and highest possible scores are respectively 0 and 56. Higher scores indicate lower sleep quality.

  3. The Postpartum Physical Symptom Severity Scale Scores [1- postpartum 8th day Time Frame: 2- Postpartum 12th week]

    Total possible scores range between 0 and 54. Higher scores obtained from this scale indicate higher severity of postpartum physical symptoms.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • primiparous;

  • reading and understanding Turkish;

  • normal term delivery;

  • no risky situations during pregnancy or delivery;

  • high score (≥65 points) from the Visual Analogue Scale to Evaluate Fatigue Severity (VAS-F),

  • score of ≥12 points from the Edinburgh Postpartum Depression Scale (EPDS);

  • episiotomy;

  • hemoglobin value of at least 10.0 mg/dL;

  • no current or past history of psychiatric illness.

Exclusion Criteria:
  • inability to communicate

  • unwillingness to participate in the research.

Contacts and Locations

Locations

Site City State Country Postal Code
1 AtaturkU Erzurum Turkey 25240

Sponsors and Collaborators

  • Ataturk University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gulsen Eryilmaz, Prof. Dr. Gulsen ERYILMAZ, Ataturk University
ClinicalTrials.gov Identifier:
NCT05295069
Other Study ID Numbers:
  • AtaturkU-GulsenEryilmaz-001
First Posted:
Mar 24, 2022
Last Update Posted:
Mar 24, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 24, 2022